Difference between revisions of "Part:BBa K3113302"
Line 73: Line 73:
 
<figure class="figure">
 
<figure class="figure">
 
                 <img src="https://2019.igem.org/wiki/images/0/0d/T--Munich--VLP_L7Ae_Fusion.png" width="75%" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
 
                 <img src="https://2019.igem.org/wiki/images/0/0d/T--Munich--VLP_L7Ae_Fusion.png" width="75%" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
−
                     <figcaption class="figure-caption"><b>Figure 4:</b> Heparin affinity purification of Virus-Like-Particles.</b> We analysed the individual fractions using the HiBiT assay. Approximately 40 % of the HiBiT signal was detected in the flow-through, 5 % in the wash and 55 % in the elution fraction.
+
                     <figcaption class="figure-caption"><b>Figure 4:Heparin affinity purification of Virus-Like-Particles.</b> We analysed the individual fractions using the HiBiT assay. Approximately 40 % of the HiBiT signal was detected in the flow-through, 5 % in the wash and 55 % in the elution fraction.
 
          
 
          
  

Revision as of 00:50, 22 October 2019


pCAG_Gag-HiBiT-L7Ae

This plasmid codes for the Gag coat-protein fused to an RNA-binding protein with a split luciferase in between. This construct forms virus-like particles (VLPs) which can be detected via a split luciferase assay. Through the RNA binding protein, the vesicles can be loaded with RNA.

Usage

pCAG_GAG-HiBit-L7Ae construct is a Composite part that has been designed to achieve VLP formation inside mammalian cells and enable the transport of chosen RNA information inside vesicles through L7Ae-C/D box interaction (together with construct BBa_K3113301 and BBa_K3113303).

Biology

Gag-p24 is the group specific antigen from the lentivirus HIV. It assembles at the plasma membrane and leads to vesicle budding.[1]
“The Nano-Glo® HiBiT Lytic Detection System quantifies cellular protein in minutes with high sensitivity and a broad dynamic range using a simple add-mix-read assay format.”[2] The HiBiT peptide is an 11 amino acid long tag that can be added to the protein of interest. The tagged protein can be measured with the Nano-Glo® HiBiT Detection Reagent which contains the LgBiT. Together the HiBiT, the LgBiT forms a functioning luminescent NanoBiT® enzyme.
The archaeal L7Ae and eukaryotic 15.5kD protein homologs are members of the L7Ae/15.5kD protein family that characteristically recognize K-turn motifs found in both archaeal and eukaryotic RNAs. In Archaea, the L7Ae protein uniquely binds the K-loop motif found in box C/D.[3] The k-turn is an ubiquitous structural motif in RNA forming a very tight kink in the axis of helical RNA that plays an important role in many aspects of RNA function. L7Ae is a member of a superfamily of proteins that bind k-turns in RNA, stabilizing the tightly kinked conformation. They are extremely widespread and are important in the assembly of RNA–protein complexes central to translation, splicing and site-specific RNA modification. [4]


Characterization


Transmission Electron Microscopy (TEM)

To validate that our vesicles are intact and properly shaped, we prepared purified VLPs and exosomes for transmission electron microscopy (TEM). This microscopy technique is based on a high-energy beam of electrons shown through a very thin sample fixed on a grid and allows high-resolution imaging.

Size distribution frequency of VLPs in HEK293T
Figure 1: Analysis of particle diameter distribution for VLPs secreted from HEK293T cells, calculated from 50 (unloaded, red) and 116 (loaded, blue) particles, respectively. The inset shows exemplary particles as seen in TEM highlighted with dashed lines (scalebar 100 nm). A Gaussian fit was performed on the data and the average diameter was calculated as 72 nm and 96 nm for unloaded and loaded VLPs, respectively.


Dynamic Light Scattering (DLS)

To further characterize our vesicles and determine the size distribution and sample homogeneity, we performed Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM) to determine the size and shape of our vesicles.
DLS measurements of VLP particles showed a narrow Gaussian size distribution indicating that the samples are very homogenous. Interestingly, a shift of about 30 nm is seen between cargo-loaded and unloaded VLPs; cargo-loaded particles have a mean diameter of 104 ± 14 nm, whereas unloaded vesicles showed a mean diameter of 71 ± 11 nm.

Size distribution frequency of VLPs in HEK293T
Figure 2: Dynamic light scattering (DLS) measurement of VLPs. Purified VLPs either with or without the adapter protein L7Ae were measured. Unloaded and loaded vesicles showed a narrow size distribution with mean diameters of 71 and 104 nm, respectively.


Split-luciferase bioluminescent assay: The HiBiT Assay

To prove that the BioBrick Part we designed works as expected, we performed a HiBit split-luciferase assay, which shows luminescent signal detected in fully formed VLPs. On the graph below the data shows that engineered Gag protein has been expressed in HEK293T cell line. Further on, based on this data, we have calculated the export to be in approx. 50% for transfection with as well as without adapter construct. With this, we report that Gag has successfully assembled into VLPs.


A generic square placeholder image with rounded corners in a figure.
Figure 3:Secretion efficiency of Gag vesicles calculated from HiBiT-measurements. Vesicles containing the adapter L7Ae as well as empty vesicles lacking the RNA binding protein (RBP) were secreted from HEK293T cells with comparable efficiency. In contrast, control samples transfected with mock DNA did not show any secretion. Measurements were performed for n = 6 biological replicates in a 96-well format.

Affinity Purification


We have established Heparin affinity chromatography as our method of choice for VLP purification. Figure 4 shows an exemplary chromatogram of a purification run with an increasing NaCl gradient for elution. Fractions of 1 ml were collected for each NaCl concentration up to 2 M and analyzed with an HiBiT assay to determine the absolute amount of Gag. After elution, we collected another 10 fractions with 2 M NaCl. As can be seen, these fractions showed almost no HiBiT signal, indicating that all vesicles were eluted from the column. In total, approximately 4 % of the HiBiT signal was detected in the flow-through, 5% in the wash and 55% in the elution fraction.


A generic square placeholder image with rounded corners in a figure.
Figure 4:Heparin affinity purification of Virus-Like-Particles. We analysed the individual fractions using the HiBiT assay. Approximately 40 % of the HiBiT signal was detected in the flow-through, 5 % in the wash and 55 % in the elution fraction.


qPCR Analysis

Finally, the BioBrick Part we designed works as expected since FLuc mRNA is successfully transported into VLPs through L7Ae-C/D box interaction. This has been proven through qPCR analysis of VLP content. FLuc mRNA cellular content is calculated with delta Ct analysis, where GAPDH housekeeping gene is used as background. Also taking cell confluency (70-80%) into account, we can calculate the accurate amount of Fluc RNA content/cell. On the graph below you can observe a 100-fold increase in FLuc signal/cell with our validated VLP BioBrick Part, compared to control. Furthermore, this part performs 20-fold better than a parallel construct used for exosomes.


A generic square placeholder image with rounded corners in a figure.
Figure 6: FLuc mRNA detection in cells producing exosomes (blue) and VLPs (red). All cells transfected with FLuc mRNA show detectable expression levels inside cells, which was significantly higher than for untransfected mock controls. Measurements were performed in technical duplicates (n = 2) with EEJ primers. Quantification was done via ͍delta Ct method.
Figure 7: Cargo mRNA export in exosomes and VLPs quantified via qPCR.
Figure 7: Cargo mRNA export in exosomes and VLPs quantified via qPCR. Both exosomes (blue) and VLPs (red) containing the RNA adapter L7Ae were capable of exporting FLuc mRNA whereas control cells lacking the RNA binding protein (RBP) showed no significant export. Measurements were performed in technical duplicates (n = 2) with EEJ primers. Quantification was done via standard curve measurements and assuming a confluent well with 350.000 HEK293T cells/cm2 at the time of harvesting.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 3019
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 2319

References


  1. ↑ HIV-1 Gag: a Molecular Machine Driving Viral Particle Assembly and Release Heinrich G. Göttlinger Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston
  2. ↑ https://www.promega.de/products/protein-quantitation-and-detection/protein-quantitation/nano-glo-hibit-lytic-detection-system/?catNum=N3030
  3. ↑ Gagnon, Keith T et al. “Signature amino acids enable the archaeal L7Ae box C/D RNP core protein to recognize and bind the K-loop RNA motif.” RNA (New York, N.Y.) vol. 16,1 (2010): 79-90. doi:10.1261/rna.1692310
  4. ↑ Lilley, D. M. J. (2019). "The L7Ae proteins mediate a widespread and highly functional protein–RNA interaction." The Biochemist 41(2): 40-44.